Dominick Colangelo Vericel Corp (VCEL) insider trading activity

Dominick Colangelo is President and CEO of Vericel Corp. Currently has a direct ownership of 220,937 shares of VCEL, which is worth approximately $13.2 Million. The most recent transaction as insider was on Dec 14, 2023, when has been sold 12,000 shares (Common Stock) at a price of $3.57 per share, resulting in proceeds of $42,840. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 221K

0% 3M change

29.97% 12M change

Total Value Held $13.2 Million

Dominick Colangelo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 14 2023	BUY Exercise of conversion of derivative security	$42,840 $3.57 p/Share	12,000 Added 6.19%	181,985 Common Stock
Dec 13 2023	SELL Bona fide gift	-	6,757 Reduced 3.82%	169,985 Common Stock
Dec 13 2023	SELL Open market or private sale	$408,360 $34.03 p/Share	12,000 Reduced 6.59%	169,985 Common Stock
Dec 13 2023	BUY Exercise of conversion of derivative security	$42,840 $3.57 p/Share	12,000 Added 6.19%	181,985 Common Stock
Dec 07 2023	SELL Open market or private sale	$406,080 $33.84 p/Share	12,000 Reduced 6.36%	176,742 Common Stock
Dec 07 2023	BUY Exercise of conversion of derivative security	$42,840 $3.57 p/Share	12,000 Added 5.98%	188,742 Common Stock
Dec 06 2023	SELL Open market or private sale	$426,828 $34.43 p/Share	12,397 Reduced 6.55%	176,742 Common Stock
Dec 06 2023	BUY Exercise of conversion of derivative security	$44,257 $3.57 p/Share	12,397 Added 6.15%	189,139 Common Stock
Feb 19 2023	SELL Payment of exercise price or tax liability	$123,544 $29.82 p/Share	4,143 Reduced 2.3%	175,808 Common Stock
Feb 19 2023	BUY Exercise of conversion of derivative security	-	8,938 Added 4.73%	179,951 Common Stock
Feb 18 2023	SELL Payment of exercise price or tax liability	$161,713 $29.82 p/Share	5,423 Reduced 3.07%	171,013 Common Stock
Feb 18 2023	BUY Exercise of conversion of derivative security	-	11,700 Added 6.22%	176,436 Common Stock
Feb 11 2023	SELL Payment of exercise price or tax liability	$102,989 $29.3 p/Share	3,515 Reduced 2.09%	164,736 Common Stock
Feb 11 2023	BUY Exercise of conversion of derivative security	-	7,500 Added 4.27%	168,251 Common Stock
Feb 06 2023	SELL Payment of exercise price or tax liability	$99,541 $30.6 p/Share	3,253 Reduced 1.98%	160,751 Common Stock
Feb 06 2023	BUY Exercise of conversion of derivative security	-	6,938 Added 4.06%	164,004 Common Stock
Jan 10 2023	SELL Open market or private sale	$1,083,517 $27.13 p/Share	39,938 Reduced 20.27%	157,066 Common Stock
Jan 10 2023	BUY Exercise of conversion of derivative security	$1,030,400 $25.8 p/Share	39,938 Added 16.86%	197,004 Common Stock
Feb 19 2022	SELL Payment of exercise price or tax liability	$135,238 $34.9 p/Share	3,875 Reduced 2.42%	156,432 Common Stock
Feb 19 2022	BUY Exercise of conversion of derivative security	-	8,937 Added 5.28%	160,307 Common Stock
Feb 11 2022	SELL Payment of exercise price or tax liability	$114,630 $35.26 p/Share	3,251 Reduced 2.1%	151,370 Common Stock
Feb 11 2022	BUY Exercise of conversion of derivative security	-	7,500 Added 4.63%	154,621 Common Stock
Feb 06 2022	SELL Payment of exercise price or tax liability	$103,392 $33.91 p/Share	3,049 Reduced 2.03%	147,121 Common Stock
Feb 06 2022	BUY Exercise of conversion of derivative security	-	6,937 Added 4.42%	150,170 Common Stock
Apr 19 2021	SELL Open market or private sale	$2,326,800 $58.17 p/Share	40,000 Reduced 21.86%	142,973 Common Stock

Also insider at

TRVI

Trevi Therapeutics, Inc. Healthcare